Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants Priority Review Designation for HTX-011

americanpharmaceuticalreviewJanuary 03, 2019

Tag: FDA , Heron Therapeutics , HTX-011 , Postoperative Pain

PharmaSources Customer Service